Global Sugar-Based Excipients Market Forecast, Trend Analysis And Competition Tracking: 2015 - 2031
-
28594
-
May 2023
-
168
-
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Sugar-Based Excipients Market Overview
The global sugar-based excipients market is valued at USD XX.XX Mn in 2021, and is projected to register а САGR of XX% by 2031.
Excipients are substances that are commonly used in pharmaceuticals for the appropriate administration and are torpid components that are used to support active ingredients of medicine and long-term stabilization, bulking up solid formulations. These products are generally available in different forms, such as gums, starch, and syrup, among others.
Excipients add flavor to a given medicine and are usually coated in different colors and making it look different. This helps in reducing viscosity and improving the solubility of a drug. Excipients consisting of sugar and polymers, and even human starch gelatin. Sugar-based excipients are well-known excipients used in orally prescribed medicines. These excipients are primarily used in antibiotics and patient syrups as well as in glycerol, sucrose, and sorbitol among others.
Among sugar-based excipients, mannitol is the costliest diluent form of an excipient that is used as a refreshment component in chewable tablets. Certain research center has raised some doubts about sugar-based excipient purity claiming that they found traces of impurities that may be a risk to patients. They even imply that impurity has the propensity to stimulate dangerous immune responses in patients.
Global Sugar-Based Excipients Market Revenue Outlook:
Factors such as growing usage of co-processed excipients and growing progress of Orally Disintegrating Tablets (ODTS) are expected to fuel prospects for additional revenue growth in this global industry in the years to come. An increase in new drug advancements and the increasing usage of excipients, and co-processed excipients to enhance bioavailability, dissolution, and fragmentation of Active Pharmaceutical Ingredients (API), multiplying the number of both geriatric and pediatric populations are further propelling the expansion of the sugar-based excipients market as a whole.
However, several limitations, such as a lack of FDA-approved manufacturing locations due to stringent regulatory requirements are expected to hinder this industry’s revenue growth trajectory over the next decade.
Regional Analysis:
The global sugar excipients market is segmented into North America, Europe, the Asia Pacific, South America, as well as the Middle East, and Africa.
Markets in Europe are expected to account for the highest revenue share of this global market. Europe’s highest revenue share may primarily be chalked-up to the increased production of generic drugs and investments in drug development, and favorable government initiatives in the region.
The immense presence of large-scale pharmaceutical companies as well as the increasing demand for generic drugs is key factors anticipated to contribute to the overall revenue growth of this market in North America.
The Asia Pacific is anticipated to register the fastest CAGR in the years to come as a direct result of the notable expansion of its healthcare sector, as well as various advancements in the pharmaceutical industry, a flourishing scientific base that is more than capable of catering to its consumers, favorable government policies, and low-cost manufacturing benefits in this region.
COVID-19 Impact Analysis On Sugar-Based Excipients Market:
The COVID-19 pandemic has had an adverse impact on almost all industries across the world. At the beginning of 2021, the coronavirus began to spread around the world. Millions of individuals across the globe were infected with this virus, and most countries around the world imposed strict lockdowns, resulting in travel restrictions and work stoppage orders. Except for those industries that were engaged with the production and distribution of medical supplies and other life support products, most other industries were greatly impacted in a negative manner. The global sugar-based excipients industry was no exception.
Notable Developments in the Industry:
- In July 2021, US-based company Cargill invested USD 45 million in the soluble fiber market in Poland. This funding added soluble fibers to its European portfolio of starches, sweeteners, and texturizers due to the high demand for reduced-sugar products.
Competitive Landscape:
The global sugar excipients market landscape appears moderately competitive and consists of several major players. Some of these companies are - DFE Pharma, ADM, Ashland, and Roquette Freres among others.
- Roquette Frères
- Ashland
- BASF SE
- Associated British Foods plc
- MEGGLE GmbH & Co. KG
- ADM
- Cargill Incorporated.
- Colorcon
- FMC Corporation
- The Lubrizol Corporation
- DFE Pharma
- Other Key Players
Report Scope
- Forecast Period: 2022-2031
- Actual Year: 2021
- Historical Data Available for: 2015-2020
Key Regions Covered
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Segments Covered Under the Global Sugar Excipients Market are:
By Type
- Powders/granules
- Direct Compression Sugars
- Crystals
- Syrups
By Product Type
- Actual Sugars
- Sugar Alcohols
- Artificial Sweeteners
By Functionality
- Fillers & Diluents
- Flavoring Agents
- Tonicity Agents
- Other Functionalities
By Formulation
- Oral Formulations
- Parenteral Formulations
- Topical Formulations
- Other Formulations
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- Roquette Frères
- Ashland
- BASF SE
- Associated British Foods plc
- MEGGLE GmbH & Co. KG
- ADM
- Cargill Incorporated.
- Colorcon
- FMC Corporation
- The Lubrizol Corporation
- DFE Pharma
- Other Key Players
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!